Sharon Lim Selected Research

Sharon Lim Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 12/2009
9	Neoplasm Metastasis (Metastasis) 08/2017 - 12/2009
5	Obesity 10/2021 - 01/2009
3	Vascular Remodeling 06/2015 - 12/2011
2	Leukemia 01/2018 - 06/2013
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 06/2013
2	Blast Crisis (Blast Phase) 01/2018 - 06/2013
2	Anemia 10/2014 - 12/2011
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Weight Loss (Weight Reduction) 10/2021
1	Morbid Obesity 10/2021
1	Pseudohypoparathyroidism 10/2021
1	Squamous Cell Carcinoma of Head and Neck 07/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2015
1	Melanoma (Melanoma, Malignant) 06/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2015
1	Insulin Resistance 10/2014
1	Lymphatic Metastasis 09/2014
1	Atherosclerotic Plaque (Atheroma) 07/2013
1	Vascular Diseases (Vascular Disease) 12/2011
1	Familial Exudative Vitreoretinopathies 03/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2011
1	Familial Primary Pulmonary Hypertension 01/2011
1	Splenomegaly 12/2009
1	Hepatomegaly 12/2009
1	Prostatic Neoplasms (Prostate Cancer) 12/2008

Drug/Important Bio-Agent (IBA)

7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 12/2009
4	Becaplermin (PDGF-BB)FDA Link 08/2017 - 12/2011
2	Hormones (Hormone)IBA 10/2021 - 12/2009
2	Phosphotransferases (Kinase)IBA 01/2018 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 07/2016 - 01/2013
2	Sunitinib (Sutent)FDA Link 01/2016 - 03/2011
2	Messenger RNA (mRNA)IBA 11/2014 - 12/2011
2	LipidsIBA 10/2014 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 06/2013 - 12/2011
2	Platelet-Derived Growth FactorIBA 01/2013 - 12/2011
2	Angiogenesis Modulating AgentsIBA 05/2010 - 01/2009
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	AntigensIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 10/2021
1	MelanocortinsIBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2018
1	Nonesterified Fatty Acids (NEFA)IBA 07/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2017
1	Indicators and Reagents (Reagents)IBA 07/2016
1	Peptide Initiation Factors (Initiation Factor)IBA 04/2016
1	tdTomatoIBA 01/2016
1	Transferrin Receptors (Transferrin Receptor)IBA 10/2015
1	IronIBA 10/2015
1	Free RadicalsIBA 10/2015
1	ArtesunateIBA 10/2015
1	CarbonIBA 10/2015
1	Antimalarials (Antimalarial Agents)IBA 10/2015
1	Vascular Endothelial Growth Factor BIBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 11/2014
1	Type I Tumor Necrosis Factor ReceptorsIBA 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2013
1	Apolipoproteins E (ApoE)IBA 07/2013
1	ApolipoproteinsIBA 07/2013
1	LDL Receptors (LDL Receptor)IBA 07/2013
1	CateninsIBA 06/2013
1	guanosine 5'-monophosphorothioateIBA 06/2013
1	Retinaldehyde (Retinal)IBA 12/2011
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2011
1	Oxygen (Dioxygen)IBA 12/2011
1	Erythropoietin FDA Link 12/2011
1	Cysteine (L-Cysteine)FDA Link 03/2011
1	Angiogenesis InhibitorsIBA 03/2011
1	Cytostatic AgentsIBA 03/2011
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2008

Therapy/Procedure

14	Therapeutics 01/2022 - 03/2011
1	Pancreatectomy 02/2013
1	Drug Therapy (Chemotherapy) 03/2011